Levothyroxine ingestions in children: an analysis of 78 cases.
A series of 78 cases of accidental levothyroxine ingestion in children (less than 12 years old) with treatment limited to ipecac-induced emesis and a single oral dose of activated charcoal is presented. No patient received any form of dialysis or hemoperfusion, propylthiouracil, cholestyramine, steroids, or serial doses of oral activated charcoal. Propranolol was used in one case despite the absence of clinical manifestations of toxicity. Only four children developed symptoms, limited to modest fever (38.3 degrees C), supraventricular tachycardia (120-176 beats/min), lethargy, irritability, vomiting, diarrhea, and abdominal pain. Peak T4RIA values in three patients were 32.8, 30.0, and 26.4 micrograms/dl, respectively, and two of these patients remained asymptomatic. Initial therapy for acute levothyroxine ingestions in children can be safely limited to routine gastrointestinal decontamination. Hospitalization or prophylactic treatment with propranolol, propylthiouracil, corticosteroids, cholestyramine, or extracorporeal detoxification are unnecessary in the early asymptomatic phase.
Litovitz
T L
TL
White
J D
JD
D002606:Charcoal / Q000627:therapeutic use; D002648:Child; D002675:Child, Preschool; D004630:Emergencies; D006801:Humans; D007223:Infant; D007486:Ipecac / Q000627:therapeutic use; D013963:Thyroid Hormones / Q000097:blood; D013974:Thyroxine / Q000506:poisoning*; D014839:Vomiting / Q000139:chemically induced
D013963:Thyroid Hormones; D002606:Charcoal; D007486:Ipecac; D013974:Thyroxine